| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/26/2004 | US20040038966 Cyclic amine derivatives and use thereof |
| 02/26/2004 | US20040038949 Inhibitors of the enzyme CYP24; useful for treating cell-proliferative disorders and for promoting cell differentiation. |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/26/2004 | US20040038910 Comprises L-arabinose and sucrose within food or beverage |
| 02/26/2004 | US20040038889 Fumaric acid amides |
| 02/26/2004 | US20040038887 Copolymers for suppression of autoimmune diseases, and methods of use |
| 02/26/2004 | US20040038886 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038877 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038402 Gene therapy; for production of transgenic animal models |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038293 Antibodies to human cd154 |
| 02/26/2004 | US20040038265 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 02/26/2004 | US20040038238 Comprises chimeric membrane proteins for diagnosis, treatment and prevention of inflammation, cancer, metabolic, gastrointestinal and autoimmune disorders |
| 02/26/2004 | US20040038236 Mutation associated with epilepsy |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040038209 Comprises nucleotide sequences coding beta -carotene dioxygenase which cleaves beta carotene and produces vitamin a aldehyde; improving nutritional value of plants, microorganisms and animal feeds |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040037022 Aminoalcohol derivatives |
| 02/26/2004 | CA2835747A1 Compositions comprising dietary fat complexer and methods for their use |
| 02/26/2004 | CA2677430A1 Compositions comprising dietary fat complexer and methods for their use |
| 02/26/2004 | CA2495409A1 Diaryl compounds as monoamine reuptake inhibitors |
| 02/26/2004 | CA2494847A1 Enos mutants useful for gene therapy |
| 02/26/2004 | CA2493245A1 Novel quinuclidine derivatives and their use |
| 02/25/2004 | EP1391514A1 Pharmaceutical composition for treatment of angiogenesis-dependent conditions |
| 02/25/2004 | EP1391460A1 Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 02/25/2004 | EP1391457A1 Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors |
| 02/25/2004 | EP1390740A1 Methods and formulations for increasing the affinity of a 1? adenosine receptor ligands for the a 1? adenosine receptor |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 02/25/2004 | EP1390508A2 A retinoic acid metabolizing cytochrome p450 |
| 02/25/2004 | EP1390490A2 Muscle-specific expression vectors |
| 02/25/2004 | EP1390470A2 Production of alpha-lipoic acid |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390391A1 Transporters and ion channels |
| 02/25/2004 | EP1390385A2 Nucleic acid based modulation of female reproductive diseases and conditions |
| 02/25/2004 | EP1390378A1 Pharmaceutically active uridine esters |
| 02/25/2004 | EP1390366A1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 02/25/2004 | EP1390363A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| 02/25/2004 | EP1390362A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 02/25/2004 | EP1390361A2 Melanocortin receptor ligands |
| 02/25/2004 | EP1390353A1 Triazole-derived kinase inhibitors and uses thereof |
| 02/25/2004 | EP1390349A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| 02/25/2004 | EP1390345A1 Polythiourea lipid derivatives |
| 02/25/2004 | EP1390073A2 Compositions having enhanced pharmacokinetic characteristics |
| 02/25/2004 | EP1390072A2 Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes |
| 02/25/2004 | EP1390061A2 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 02/25/2004 | EP1390060A2 Use of lp82 to treat body weight disorders |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP1390054A2 Mu-conopeptides |
| 02/25/2004 | EP1390051A2 Food compositions for reducing insulin resistance |
| 02/25/2004 | EP1390025A1 Coenzyme q and eicosapentaenoic acid (epa) |
| 02/25/2004 | EP1292293B1 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same |
| 02/25/2004 | EP1222171B1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 02/25/2004 | EP1140931B1 5ht1 antagonists for antidepressant therapy |
| 02/25/2004 | EP1117392B1 Method for preventing or delaying catheter-based revascularization |
| 02/25/2004 | EP1087934B1 Aminocyclohexyl ether compounds and uses thereof |
| 02/25/2004 | EP1037612B1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 02/25/2004 | EP0988797B1 Use of compositions for postgastrectomic mineral supply |
| 02/25/2004 | EP0981526B1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 02/25/2004 | EP0758897B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 02/25/2004 | EP0751957B1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
| 02/25/2004 | CN1478081A Substituted 2-znilino-benzimidazoles and use thereof as NHE-inhibitors |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1478077A Benzamide compounds as APOB secretion inhibitors |
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/25/2004 | CN1478074A Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/25/2004 | CN1477976A Combination of GABA agonists and aldose reductase inhibitors |
| 02/25/2004 | CN1477975A Combination of GABA agonists and sorbitol dehydrogenase inhibitors |
| 02/25/2004 | CN1477974A Antiobestic agents and health foods |
| 02/25/2004 | CN1477968A Methods for treating rheumatic diseases using soluble CTLA4 molecule |
| 02/25/2004 | CN1477967A Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1477959A Compositions and methods for lowering plasma lipoprotein (a) and risk factors of cardiovascular diseases |
| 02/25/2004 | CN1477950A Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of critically ill, chronically ill and people with malnutrition |
| 02/25/2004 | CN1477113A Recombinant human fatty acid oxidation protein, its production method and application |
| 02/25/2004 | CN1477102A Sugarapple plant extract with action of resisting diabetes, medicinal application and preparation method |
| 02/25/2004 | CN1476893A Medince composition containing huanzupulo for curing diabetes |
| 02/25/2004 | CN1476882A Medicine with function of reducing blood sugar and its preparation method |
| 02/25/2004 | CN1476872A Medicine composition for curing diabetes |
| 02/25/2004 | CN1476867A Freeze-dried garlic powder preparation and its preparation method |
| 02/25/2004 | CN1476854A Medicine tea for curing diabetes |
| 02/25/2004 | CN1476846A Medicine for preventing and curing diseases and prolonging life and its method |
| 02/25/2004 | CN1476830A Tea-polyphenol soft capsule and its preparation process |
| 02/25/2004 | CN1476828A Suspended preparation of biguanide vanadium complex-medicine for curing diabetes and its application |
| 02/25/2004 | CN1139589C Tetrahydroimidazo [2,1-a] isoquinoline derivatives |
| 02/25/2004 | CN1139584C Heterocyclic compounds, method for preparing and medicine composition containing same |
| 02/25/2004 | CN1139398C Chinese medicine for treating diabetic neural lesion |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696495 Treatment of disorders secondary to organic impairments |
| 02/24/2004 | US6696479 Crystalline forms |
| 02/24/2004 | US6696474 Such as 8-(5-methyl-2-phenyl-oxazol-4-yl)-2-pyrrol-1-yl-oct-4-ynoic acid; noninsulin dependent diabetes mellitus |
| 02/24/2004 | US6696470 Pyridylthiophene compounds |
| 02/24/2004 | US6696467 Quinoline derivatives |
| 02/24/2004 | US6696464 Triazolo-pyridines anti-inflammatory compounds |